145 related articles for article (PubMed ID: 36050601)
1. EIF3B stabilizes PTGS2 expression by counteracting MDM2-mediated ubiquitination to promote the development and progression of malignant melanoma.
Fang P; Han Y; Qu Y; Wang X; Zhang Y; Zhang W; Zhang N; Li G; Ma W
Cancer Sci; 2022 Dec; 113(12):4181-4192. PubMed ID: 36050601
[TBL] [Abstract][Full Text] [Related]
2. EIF3B stabilizes PCNA by counteracting SYVN1-mediated ubiquitination to serve as a promotor in cholangiocarcinoma.
Huang R; Nie W; Mi L; Yao C; Zhu H
Aging (Albany NY); 2024 Apr; 16(8):7311-7330. PubMed ID: 38687509
[TBL] [Abstract][Full Text] [Related]
3. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
[TBL] [Abstract][Full Text] [Related]
5. Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer.
Xiang P; Sun Y; Fang Z; Yan K; Fan Y
Mamm Genome; 2020 Aug; 31(7-8):197-204. PubMed ID: 32556998
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells.
Liang H; Ding X; Zhou C; Zhang Y; Xu M; Zhang C; Xu L
Neurol Sci; 2012 Oct; 33(5):1057-62. PubMed ID: 22234522
[TBL] [Abstract][Full Text] [Related]
7. Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization.
Wang H; Ru Y; Sanchez-Carbayo M; Wang X; Kieft JS; Theodorescu D
Clin Cancer Res; 2013 Jun; 19(11):2850-60. PubMed ID: 23575475
[TBL] [Abstract][Full Text] [Related]
8. Eukaryotic initiation factor 3b regulates the development and progression of breast cancer.
Li Y; Zhao J; Yuan Z; Yuan D; Fang M; Xie M; Xia M
Am J Cancer Res; 2023; 13(5):2188-2200. PubMed ID: 37293180
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of eukaryotic translation initiation factor 3b inhibited proliferation and metastasis of gastric cancer.
Ma F; Li X; Ren J; Guo R; Li Y; Liu J; Sun Y; Liu Z; Jia J; Li W
Cell Death Dis; 2019 Aug; 10(9):623. PubMed ID: 31423012
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA RP11-284P20.2 promotes cell proliferation and invasion in hepatocellular carcinoma by recruiting EIF3b to induce c-met protein synthesis.
Fang QL; Zhou JY; Xiong Y; Xie CR; Wang FQ; Li YT; Yin ZY; Luo GH
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32100822
[TBL] [Abstract][Full Text] [Related]
11. Establishing a Prognostic Model Based on Ulceration and Immune Related Genes in Melanoma Patients and Identification of EIF3B as a Therapeutic Target.
Wu Z; Lei K; Xu S; He J; Shi E
Front Immunol; 2022; 13():824946. PubMed ID: 35273605
[TBL] [Abstract][Full Text] [Related]
12. RNA interference-mediated silencing of eukaryotic translation initiation factor 3, subunit B (EIF3B) gene expression inhibits proliferation of colon cancer cells.
Wang Z; Chen J; Sun J; Cui Z; Wu H
World J Surg Oncol; 2012 Jun; 10():119. PubMed ID: 22734884
[TBL] [Abstract][Full Text] [Related]
13. Eukaryotic Translation Initiation Factor 3 Subunit B Is a Promoter in the Development and Progression of Pancreatic Cancer.
Ren H; Mai G; Liu Y; Xiang R; Yang C; Su W
Front Oncol; 2021; 11():644156. PubMed ID: 33996561
[No Abstract] [Full Text] [Related]
14. EIF3B promotes cancer progression in pancreatic cancer.
Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
Scand J Gastroenterol; 2021 Mar; 56(3):281-288. PubMed ID: 33459066
[TBL] [Abstract][Full Text] [Related]
15. EIF3B correlates with advanced disease stages and poor prognosis, and it promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
Tian Y; Zhao K; Yuan L; Li J; Feng S; Feng Y; Fang Z; Li H; Deng R
Cancer Biomark; 2018; 23(2):291-300. PubMed ID: 30198870
[TBL] [Abstract][Full Text] [Related]
16. Novel RNA-binding protein P311 binds eukaryotic translation initiation factor 3 subunit b (eIF3b) to promote translation of transforming growth factor β1-3 (TGF-β1-3).
Yue MM; Lv K; Meredith SC; Martindale JL; Gorospe M; Schuger L
J Biol Chem; 2014 Dec; 289(49):33971-83. PubMed ID: 25336651
[TBL] [Abstract][Full Text] [Related]
17. Effects of EIF3B gene downregulation on apoptosis and proliferation of human ovarian cancer SKOV3 and HO-8910 cells.
Wang L; Ouyang L
Biomed Pharmacother; 2019 Jan; 109():831-837. PubMed ID: 30551537
[TBL] [Abstract][Full Text] [Related]
18. Eukaryotic translation initiation factor 3 subunit B could serve as a potential prognostic predictor for breast cancer.
Song S; Liu J; Zhang M; Gao X; Sun W; Liu P; Wang Y; Li J
Bioengineered; 2022 Feb; 13(2):2762-2776. PubMed ID: 35040374
[TBL] [Abstract][Full Text] [Related]
19. Eukaryotic initiation factor 3B is overexpressed and correlates with larger tumor size, advanced FIGO stage, and shorter overall survival in epithelial ovarian cancer patients.
Zhao N; Guo Y; He Y; Chen Y; Xing J
J Clin Lab Anal; 2020 Aug; 34(8):e23354. PubMed ID: 32419232
[TBL] [Abstract][Full Text] [Related]
20. EIF3B Associates with Exacerbated Clinical Features, Poor Treatment Response and Survival in Adult Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Patients.
Zhu F; Fu Y; He X
Technol Cancer Res Treat; 2021; 20():15330338211041464. PubMed ID: 34617851
[No Abstract] [Full Text] [Related]
[Next] [New Search]
